Inhibition by SK&F96365 of NO-mediated relaxation induced by Ca2+-ATPase inhibitors in rat thoracic aorta

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1544-1548

  Moritoki, Hideki ^a   Hisayama, Tetsuhiro ^a   Takeuchi, Shougo ^a   Kondoh, Wataru ^a   Inoue, Shinnichi ^a   Kida, Kan ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Aorta; Ca2+ influx; Cyclopiazonic acid; Endothelium; NO formation; Relaxation; SIC F96365; Thapsigargin

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIMYCIN; CALCIUM CHANNEL; CALCIUM ION; CYCLIC GMP; CYCLOPIAZONIC ACID; NICKEL; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; THAPSIGARGIN;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; CYCLIC GMP; ENDOTHELIUM, VASCULAR; IMIDAZOLES; INDOLES; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NICKEL; NITRIC OXIDE; RATS; RATS, WISTAR; TERPENES; THAPSIGARGIN;

EID: 0029932374     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15319.x     Document Type: Article

References (34)

1. ADEAGBO, A.S.O. & TRIGGLE, C.R. (1991). Effects of some inorganic divalent cations and protein kinase C inhibitors on endothelium-dependent relaxation in rat isolated aorta and mesenteric arteries. J. Cardiovasc. Pharmacol., 18, 511-521.
2. COLDEN-STANFIELD, M., SCHILLING, W.P., RITCHIE, A.K., ESKIN, S.G., NAVARRO, L.T. & KUNZE, D.L. (1987). Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ. Res., 61, 632-640.
3. 2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J. Biol. Chem., 267, 2318-2324.
4. DEMIREL, E., LASKEY, R.E., PURKERSON, S. & VAN BREEMEN, C. (1993). The passive calcium leak in cultured porcine aortic endothelial cells. Biochem. Biophys. Res. Commun., 191, 1197-1203.
5. DOLOR, R.J., HURWITZ, L.M., MIRZA, Z., STRAUSS, H.C. & WHORTON, A.R. (1992). Regulation of extracellular calcium entry in endothelial cells: role of intracellular calcium pool. Am. J. Physiol., 262, C171-C181.
6. GERICKE, M., DROOGMANS, G. & NILIUS, B. (1993). Thapsigargin discharges intracellular calcium stores and induces transmembrane currents in human endothelial cells. Pflügers Arch., 422, 552-557.
7. GRAIER, W.F., GROSCHNER, K., SCHMIDT, K. & KUKOVETZ, W.R. (1992). SK&F96365 inhibits histamine-induced formation of endothelium-derived relaxing factor in human endothelial cells. Biochem. Biophys. Res. Commun., 186, 1539-1545.
8. HALLAM, T.J., JACOB, R. & MERRITT, J.E. (1989). Influx of bivalent cations can be independent of receptor stimulation in human endothelial cells. Biochem. J., 259, 125-129.
9. HALLAM, T.J. & RINK, T.J. (1985). Agonist stimulates divalent cation channels in the plasma membrane of human platelets. FEBS Lett., 186, 175-179.
10. 2+ entrance via cation currents in endothelial cells. Life Sci., 56, 11-17.
11. JACOB, R. (1990). Agonist-stimulated divalent cation entry into single cultured human umbilical vein endothelial cells. J. Physiol., 421, 55-77.
12. JAYAKODY, R.L., KAPPAGODA, C.T., SENARATNE, M.P.J. & SREEHARAN, N. (1987). Absence of effect of calcium antagonists on endothelium-dependent relaxation in rabbit aorta. Br. J. Pharmacol., 91, 155-164.
13. JOHNS, A., LATEGAN, T.W., LODGE, N.J., RYAN, U.N.A.S., VAN BREEMEN, C. & ADAMS, D.J. (1987). Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells. Tissue & Cell, 19, 733-745.
14. 2+-ATPase inhibitor, stimulates NO formation in rat aortic endothelium. Jpn. J. Pharmacol., 61, Suppl. 1, 234p.
15. 2+ entry via receptor-operated channels. Jpn. J. Pharmacol., 64, Suppl.1,274p.
16. 2+ influx via receptor-operated channels. Can. J. Physiol. Pharmacol., 72, Suppl. 1, 112.
17. KRAUTWURST, D., HESCHELER, J., ARNDTS, D., LÖSEL, W., HAMMER, R. & SCHULTZ, G. (1993). Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells. Mol. Pharmacol., 43, 655-659.
18. MERRITT, J.E., ARMSTRONG, W.P., BENHAM, C.D., HALLAM, T.J., JACOB, R., JAXA-CHAMIEC, A., LEIGH, B.K., MCCARTHY, S.A., MOORES, K.E. & RINK, T.J. (1990). SK&F96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J., 271, 515-522.
19. 2+-ATPase inhibitor, relaxes rat aorta via nitric oxide formation. Life Sci., 54, PL153-158.
20. 2+-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation. Br. J. Pharmacol., 111, 655-662.
21. MÜLSCH, A., BASSENGE, E. & BUSSE, R. (1989). Nitric oxide synthesis in endothelial cytosol: Evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn-Schmied. Arch. Pharmacol., 340, 767-770.
22. 3-independent manner. Am. J. Physiol., 268, (Heart Circ. Physiol. 37), H138-H146.
23. 2+ influx. Nature, 364, 809-814.
24. 2+-influx pathway. Biochem. J., 284, 521-530.
25. SCHILLING, W.P., RAJAN, L. & STROBL-JAGER, E. (1989). Characterization of the bradykinin-stimulated calcium influx pathway of cultured vascular endothelial cells. J. Biol. Chem., 264, 12838-12848.
26. SCHILLING, W.P., RITCHIE, A.K., NAVARRO, L.T. & ESKIN, S.G. (1988). Bradykinin-stimulated calcium influx in cultured bovine aortic endothelial cells. Am. J. Physiol., 255, (Heart Circ. Physiol. 24), H219-H227.
27. SCHMIDT, K., MAYER, B. & KUKOVETZ, W.R. (1989). Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur. J. Pharmacol., 170, 157-166.
28. SCHWARZ, G., DROOGMANS, G. & NILIUS, B. (1994). Multiple effects of SK&F96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium, 15, 45-54.
29. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem., 264, 17816-17823.
30. TAKEMURA, H., HUGHES, A.R., THASTRUP, O. & PUTNEY Jr. J.W. (1989). Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. J. Biol. Chem., 264, 12266-12271.
31. 2+-ATPase inhibitor, thapsigargin. Agents Actions, 29, 8-15.
32. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A., 87, 2466-2470.
33. ++-influx and subsequent prostacyclin synthesis in human endothelial cells. Biochem. Biophys. Res. Commun., 195, 874-880.
34. 2+ in EDRF release in rat aorta. J. Vasc. Res., 31, 18-24.